The PE Ratio as of November 2024 (TTM) for Lipocine Inc. (LPCN) is -6.87

According to Lipocine Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.87. This represents a change of 383.98% compared to the average of -1.42 of the last 4 quarters.

Lipocine Inc. (LPCN) Historical PE Ratio (quarterly & annually)

How has LPCN PE Ratio performed in the past?

The mean historical PE Ratio of Lipocine Inc. over the last ten years is -12.02. The current -6.87 PE Ratio has changed 5.62% with respect to the historical average. Over the past ten years (40 quarters), LPCN's PE Ratio was at its highest in in the March 2024 quarter at 2.00. The PE Ratio was at its lowest in in the December 2015 quarter at -12.74.

Lipocine Inc. (LPCN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lipocine Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lipocine Inc. (LPCN) Average PE Ratio

How has LPCN PE Ratio performed in the past?

The current PE Ratio of Lipocine Inc. (LPCN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lipocine Inc. (LPCN) PE Ratio vs. Peers

How is LPCN’s PE Ratio compared to its peers?

Lipocine Inc.’s PE Ratio is greater than Sigilon Therapeutics, Inc. (-16.76), less than Reviva Pharmaceuticals Holdings, Inc. (-1.19), less than ZyVersa Therapeutics, Inc. (-0.00), less than Kiromic BioPharma, Inc. (-1.34), less than Unicycive Therapeutics, Inc. (-1.63), less than Checkpoint Therapeutics, Inc. (-3.48), less than Mustang Bio, Inc. (-0.32), less than Fortress Biotech, Inc. (-0.62), less than Kodiak Sciences Inc. (-1.70), greater than Ardelyx, Inc. (-17.26), less than Zura Bio Limited (-5.60), less than Hepion Pharmaceuticals, Inc. (-0.20), less than AVROBIO, Inc. (2.07), less than Verastem, Inc. (-1.72), less than Reviva Pharmaceuticals Holdings, Inc. (0), less than Eyenovia, Inc. (-1.19), less than Cognition Therapeutics, Inc. (-0.20), less than TransCode Therapeutics, Inc. (-0.50), less than null (-0.38),

Build a custom stock screener for Lipocine Inc. (LPCN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lipocine Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lipocine Inc. (LPCN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lipocine Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.